StonvexLoading…
StonvexStonvexStonvexCore line items from KSCP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.34M | $10.80M | $12.80M | $5.63M |
Operating Income | $-33.89M | $-29.68M | $-26.29M | $-31.97M |
Net Income | $-33.81M | $-31.73M | $-22.12M | $-25.64M |
EPS (Diluted) | $-4.00 | $-10.97 | $-16.77 | $-0.72 |
Total Assets | $41.26M | $28.18M | $22.97M | $22.08M |
Total Liabilities | $13.49M | $12.40M | $15.40M | $29.89M |
Cash & Equivalents | $20.57M | $11.12M | $2.28M | $4.81M |
Free Cash Flow OCF − CapEx | $-31.00M | $-22.50M | $-24.61M | $-24.18M |
Shares Outstanding | 8.46M | 2.89M | 1.32M | 35.55M |